Stalevo is an anti-parkinsonian dopaminergic combination medication that contains carbidopa, levodopa and entacapone for the treatment of Parkinson’s disease.
The generic carbidopa, levodopa and entacapone tablets contain carbidopa, levodopa and entacapone 25/100/200mg and 37.5/150/200mg.
Stalevo is currently indicated to treat adult patients with idiopathic Parkinson’s disease in two scenarios.